SAVA stock rose 5% on the success of Biogen in slowing cognitive decline from Alzheimer's, but its Simufilam has a different target. More
Articles
Why BBBY Stock Investors Should Buckle Their Seatbelts for Sept. 29
BBBY stock could sink or swim following Bed Bath & Beyond's upcoming earnings call. Here's what to know ahead of Sept. 29. More
LYFT Stock Alert: What to Know as Lyft Pumps the Brakes on Hiring
Lyft (LYFT) stock is getting a boost on Wednesday after the ride-sharing company revealed a stop to hiring for the rest of the year. More
Why Is MindMed (MNMD) Stock Plunging 51% Today?
MNMD stock is tumbling more than 50% after the drug maker announced that it would sell shares of its stock and warrants for its shares. More
A Shot of NVAX Stock Is NOT What Your Portfolio Needs
Even before Biden's 'pandemic is over' declaration, NVAX stock struggled due to weak demand for Novavax's Covid-19 shots. More
Why Is Biogen (BIIB) Stock Up 40% Today?
Positive results from a clinical trial offer encouragement for the medical community, as well as for downtrodden BIIB stock investors. More
